{"id":50147,"date":"2012-07-25T16:12:57","date_gmt":"2012-07-25T16:12:57","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/novel-pig-model-may-be-useful-for-human-cancer-studies.php"},"modified":"2012-07-25T16:12:57","modified_gmt":"2012-07-25T16:12:57","slug":"novel-pig-model-may-be-useful-for-human-cancer-studies","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-engineering\/novel-pig-model-may-be-useful-for-human-cancer-studies.php","title":{"rendered":"Novel pig model may be useful for human cancer studies"},"content":{"rendered":"<p><p>Public  release date: 24-Jul-2012  [ |   E-mail   |  Share    ]  <\/p>\n<p>    Contact: Vicki Cohn    <a href=\"mailto:vcohn@liebertpub.com\">vcohn@liebertpub.com<\/a>    914-740-2100 x2156    Mary    Ann Liebert, Inc.\/Genetic Engineering News<\/p>\n<p>    New Rochelle, NY, July 24, 2012A naturally occurring line of    immunodeficient pigs can support the growth of human tumors    injected under their skin, offering a promising new large    animal model for studying human cancers and testing new drugs    and treatment strategies. The ability of human melanoma cells    and pancreatic carcinoma cells to grow in these pig models is    described in an article in BioResearch Open Access, a    new bimonthly peer-reviewed open access journal from Mary Ann    Liebert, Inc. (<a href=\"http:\/\/www.liebertpub.com\" rel=\"nofollow\">http:\/\/www.liebertpub.com<\/a>). The    article is available free online at the BioResearch Open    Access website (<a href=\"http:\/\/www.liebertpub.com\/biores\" rel=\"nofollow\">http:\/\/www.liebertpub.com\/biores<\/a>).  <\/p>\n<p>    Mathew Basel and colleagues, Kansas State University    (Manhattan, KS) and Iowa State University (Ames), highlight the    advantages that pig disease models offer, as they are    anatomically and physiologically more closely related to humans    than traditional rodent animal models. As a result, findings    from studies in large animal models such as pigs are more    likely to translate into similar outcomes in humans. The    authors present their findings in the article \"Human Xenografts    Are Not Rejected in a Naturally Occurring Immunodeficient    Porcine Line: A Human Tumor Model in Pigs\" (<a href=\"http:\/\/online.liebertpub.com\/doi\/full\/10.1089\/biores.2012.9902\" rel=\"nofollow\">http:\/\/online.liebertpub.com\/doi\/full\/10.1089\/biores.2012.9902<\/a>).  <\/p>\n<p>    \"This novel animal model has the potential to become a highly    useful model in cancer research studies, in addition to    providing significant opportunities for drug discovery and    other translational applications,\" says Editor-in-Chief Jane    Taylor, PhD, MRC Centre for Regenerative Medicine, University    of Edinburgh, Scotland.  <\/p>\n<p>    ###  <\/p>\n<p>    About the Journal  <\/p>\n<p>    BioResearch Open Access (<a href=\"http:\/\/www.liebertpub.com\/biores\" rel=\"nofollow\">http:\/\/www.liebertpub.com\/biores<\/a>)    is a bimonthly peer-reviewed open access journal that provides    a new rapid-publication forum for a broad range of scientific    topics including molecular and cellular biology, tissue    engineering and biomaterials, bioengineering, regenerative    medicine, stem cells, gene therapy, systems biology, genetics,    biochemistry, virology, microbiology, and neuroscience. All    articles are published within 4 weeks of acceptance and are    fully open access and posted on PubMedCentral. All journal    content is available online at the BioResearch Open    Access website (<a href=\"http:\/\/www.liebertpub.com\/biores\" rel=\"nofollow\">http:\/\/www.liebertpub.com\/biores<\/a>).  <\/p>\n<p>    About the Publisher  <\/p>\n<p>    Mary Ann Liebert, Inc., publishers (<a href=\"http:\/\/www.liebertpub.com\" rel=\"nofollow\">http:\/\/www.liebertpub.com<\/a>) is a    privately held, fully integrated media company known for    establishing authoritative peer-reviewed journals in many    promising areas of science and biomedical research, including    Tissue Engineering, Stem Cells and Development, Human Gene    Therapy and HGT Methods, and AIDS Research and Human    Retroviruses. Its biotechnology trade magazine, Genetic    Engineering & Biotechnology News (GEN), was the    first in its field and is today the industry's most widely read    publication worldwide. A complete list of the firm's 70    journals, books, and newsmagazines is available on the Mary Ann    Liebert, Inc. website (<a href=\"http:\/\/www.liebertpub.com\" rel=\"nofollow\">http:\/\/www.liebertpub.com<\/a>).  <\/p>\n<\/p>\n<p>Read more:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/www.eurekalert.org\/pub_releases\/2012-07\/mali-npm072412.php\" title=\"Novel pig model may be useful for human cancer studies\">Novel pig model may be useful for human cancer studies<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Public release date: 24-Jul-2012 [ | E-mail | Share ] Contact: Vicki Cohn <a href=\"mailto:vcohn@liebertpub.com\">vcohn@liebertpub.com<\/a> 914-740-2100 x2156 Mary Ann Liebert, Inc.\/Genetic Engineering News New Rochelle, NY, July 24, 2012A naturally occurring line of immunodeficient pigs can support the growth of human tumors injected under their skin, offering a promising new large animal model for studying human cancers and testing new drugs and treatment strategies. The ability of human melanoma cells and pancreatic carcinoma cells to grow in these pig models is described in an article in BioResearch Open Access, a new bimonthly peer-reviewed open access journal from Mary Ann Liebert, Inc <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-engineering\/novel-pig-model-may-be-useful-for-human-cancer-studies.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[3],"tags":[],"class_list":["post-50147","post","type-post","status-publish","format-standard","hentry","category-genetic-engineering"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/50147"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=50147"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/50147\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=50147"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=50147"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=50147"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}